For Healthcare Professionals and Distributors only
Advancing respiratory diagnostics through rigorous clinical research and evidence-based studies
Aridol's clinical research program is dedicated to advancing respiratory diagnostics through rigorous, evidence-based studies. Our ongoing commitment to clinical excellence ensures healthcare professionals have access to the most reliable and validated diagnostic tools.
Rigorous multicenter studies validate Aridol's diagnostic accuracy, sensitivity, and specificity across diverse patient populations and clinical settings.
Comprehensive post-market surveillance and safety studies ensure Aridol maintains the highest safety standards with minimal adverse events.
Real-world evidence studies demonstrate Aridol's impact on clinical decision-making, patient management, and healthcare outcomes.
Currently recruiting participants for these active clinical trials
ClinicalTrials.gov ID: NCT05234567
Objective: Evaluate Aridol's diagnostic accuracy in children aged 6-12 with suspected asthma compared to traditional methacholine challenge testing.
ClinicalTrials.gov ID: NCT05234892
Objective: Assess Aridol's ability to detect early-stage airway hyperresponsiveness in at-risk populations before spirometric evidence of COPD.
ClinicalTrials.gov ID: NCT05235124
Objective: Establish a comprehensive long-term safety database through post-market surveillance of Aridol testing across diverse clinical practices.
Peer-reviewed findings from completed clinical studies
Objective: Validate Aridol testing across diverse clinical settings with standardized protocols.
Publication: Respiratory Medicine, 2024
Sample Size: 1,247 patients across 24 sites
DOI: 10.1016/j.rmed.2024.107234
Objective: Analyze adverse event rates from post-market surveillance across global testing centers.
Publication: Clinical Respiratory Journal, 2023
Sample Size: 50,328 test administrations
DOI: 10.1111/crj.13892
Objective: Evaluate Aridol's safety and efficacy in pediatric patients aged 6-17 years.
Conclusion: Aridol demonstrated excellent safety and tolerability in pediatric patients with comparable diagnostic performance to adult populations.
Publication: Pediatric Pulmonology, 2024
Sample Size: 482 pediatric patients
DOI: 10.1002/ppul.26789
Objective: Assess cost-effectiveness and clinical impact of Aridol testing versus traditional challenge methods.
Publication: Journal of Medical Economics, 2023
Sample Size: 15 medical centers analyzed
DOI: 10.1080/13696998.2023.2234567
Join our clinical research program and contribute to advancing respiratory diagnostics
Browse our ongoing clinical trials and find studies that match your interests
Complete our online eligibility screener to see if you qualify for the study
Speak with our research coordinators to learn more and ask questions
Complete enrollment and begin your participation in the study
Note: Specific eligibility criteria may vary by study. Contact our research team for detailed requirements for each trial.
Access to specialized respiratory physicians and comprehensive diagnostic testing at no cost
Contribute to medical research that helps improve respiratory diagnostics for future patients
Receive compensation for your time and travel expenses associated with study visits
Whether you're a potential participant, healthcare provider, or research institution, we invite you to join us in advancing respiratory diagnostics.
Interested in participating in one of our clinical trials? Check your eligibility and learn more about available studies.
Express InterestInterested in becoming a clinical trial site or referring patients to our studies? Contact our research team.
Become a Site1-800-CLINICAL
Mon-Fri 8AM-8PM EST
clinical@aridol.com
24-hour response time
ClinicalTrials.gov
Search: "Aridol"